Examination of the effectiveness of Quasi-particle accelerator (QPA) for fibromyalgia
Not Applicable
- Conditions
- fibromyalgia
- Registration Number
- JPRN-UMIN000044620
- Lead Sponsor
- Tokushima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with implantable electronic devices (such as pacemakers) Patients with serious heart disease, kidney disease, liver disease Patients with arterial oxygen saturation <94% without oxygen Patients with severe peripheral neuropathy Persons who have lost temperature sensitivity Patients who cannot express their intention Patients with hypersensitivity, injury or lesions on the skin of the pad area (upper back and lower back) Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total score of the Japanese version of the Revised Fibromyalgia Impact Questionnaire (JFIQR) before and 4 weeks after the start of QPA treatment
- Secondary Outcome Measures
Name Time Method The changes in JFIQR domain (1), (2), (3) and each item before and 4 weeks after the start of QPA treatment